Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Nanomix Corp NNMX

Healthcare Medical Devices
Nanomix Corporation is engaged in development of mobile point-of-care diagnostics. The Company operates through its Nanomix eLab System platform and assays that provide quantitative information for use in settings where time is critical to clinical decision-making and improved patient care. The platform is designed to provide rapid test results in a handheld device at the first point of patient... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (GREY:NNMX)

Nanomix Announces Equity Investment from Senior Executive of Woodley Equipment Company, Ltd. at a Premium to Market

GlobeNewswire April 13, 2023

Nanomix Appoints Finance Veteran Chris Hetterly as Chief Financial Officer

GlobeNewswire January 25, 2023

Nanomix Enters into Distribution Agreement for the eLab System with Gepa Srl in Italy

GlobeNewswire November 29, 2022

Nanomix Enters into an Exclusive Veterinary Distribution Agreement for the eLab System with Woodley Equipment Company, Ltd.

GlobeNewswire November 9, 2022

Nanomix Enters into Multi-Country Distribution Agreement for the eLab System with Mast Group Limited

GlobeNewswire November 4, 2022

Nanomix Enters into Distribution Agreement for the eLab System with Diaclinic SpA in Chile

GlobeNewswire October 20, 2022

Nanomix Enters into Distribution Agreement for the eLab System and Future New Products with IPS Genomix s.a.l. in the Middle East

GlobeNewswire September 12, 2022

Nanomix Announces Agreement with Mobility Health to Co-Develop a Lab Development Test for Evaluating Levels of COVID-19 Circulating Antibodies

GlobeNewswire September 2, 2022

Nanomix Appoints Industry Veteran Tadd S. Lazarus, M.D., to the Board of Directors

GlobeNewswire August 31, 2022
View More News ››

Opinion & Analysis (GREY:NNMX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (GREY:NNMX)

Boston Therapeutics, Inc. (BTHE) Addressing the Diabetes Epi

Boston Therapeutics, Inc. (BTHE) Addressing the Diabetes Epidemic with Promising Drug Candidates Approximately 25.8 million Americans...
MissionIR - January 27, 2014

Boston Therapeutics, Inc. (BTHE) Prepares for Third Phase Tr

Boston Therapeutics, Inc. (BTHE) Prepares for Third Phase Trial of PAZ320 Boston Therapeutics is a pharmaceutical company focused on...
MissionIR - January 21, 2014

Boston Therapeutics, Inc. (BTHE) Heads into 2014 with Strong

Boston Therapeutics, Inc. (BTHE) Heads into 2014 with Strong, Experienced Leadership Boston Therapeutics is developing a pipeline of...
MissionIR - January 13, 2014

Boston Therapeutics, Inc. (BTHE) Tackles One of America’s Gr

Boston Therapeutics, Inc. (BTHE) Tackles One of America’s Greatest Epidemics It’s turning out to be one of the biggest epidemic waves...
MissionIR - January 6, 2014

Pivotal Phase 3 Trial a Key Objective for Boston Therapeutic

Pivotal Phase 3 Trial a Key Objective for Boston Therapeutics (BTHE) in 2014 Boston Therapeutics is a pharmaceutical company using...
MissionIR - December 27, 2013

Boston Therapeutics, Inc. (BTHE) is Creating a Better Drug t

Boston Therapeutics, Inc. (BTHE) is Creating a Better Drug to Prevent and Treat Diabetes In the United States alone, an estimated 26...
MissionIR - December 17, 2013
View more Bullboard ››

World Copper Ltd

World Copper Ltd

World Copper Ltd. is a Canada-based exploration stage junior mining company, which is engaged in the identification ...
View More »